Adamas is a California-based pharmaceutical company that develops and commercializes therapies for the treatment of neurological diseases.
Business Model:
Revenue: $74.5M
Employees: 51-200
Adamas was acquired by
Supernus Pharmaceuticals.
The acquisition happend on 2021-10-11.
Details of the transaction were not public
Address: 1900 Powell Street
City: Emeryville
State: CA
Zip: 94608
Country: US
Adamas is a California-based pharmaceutical company that develops and commercializes therapies for the treatment of neurological diseases.
Contact Phone:
+15104503500
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
4/11/2014
Ticker Symbol:
ADMS
IPO Price:
$16/share
Amount Raised:
$48M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2021 | Post-IPO Equity | $59.2M | 4/2014 | IPO | $48M |
|
7/2008 | Series C | $8M | 8/2007 | Series C | $13M | 8/2009 | Series D | $40M |
Aeris Capital AG DAG Ventures Northgate Capital Mohr Davidow |
5/2005 | Series B | 1 | $21M |
Mohr Davidow Ventures Mohr Davidow Ventures Mohr Davidow Ventures Mohr Davidow Ventures |
10/2009 | Series D | 4 | $40M |
Northgate Capital DAG Ventures Aeris Capital Mohr Davidow Ventures Northgate Capital DAG Ventures Aeris Capital Mohr Davidow Ventures |
---|
Announced Date | Name | Price |
---|---|---|
7/1996 | Future Domain |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|